Filing Flows › Treace Medical Concepts (TMCI) › R&D spending
Treace Medical Concepts (TMCI) R&D spending by quarter
Treace Medical Concepts' R&D spending was $4.5M in Q3 2026 (third quarter 2026), +3% from Q2 2026. Over the last 7 quarters it ranged from $4.4M (Q2 2026) to $5.6M (Q1 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $4.5M | +3% | -4% |
| Q2 2026 | $4.4M | -5% | -20% |
| Q1 2026 | $4.6M | +2% | -17% |
| Q4 2025 | $4.5M | -3% | — |
| Q3 2025 | $4.7M | -15% | — |
| Q2 2025 | $5.5M | -1% | — |
| Q1 2025 | $5.6M | — | — |
Q3 2026 at a glance
Treace Medical Concepts, Q3 2026: revenue $48.3M (-4% year over year), operating margin -23.9%, net loss $12.6M, operating cash flow −$3.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is Treace Medical Concepts' R&D spending?
Treace Medical Concepts' R&D spending was $4.5M in Q3 2026 (third quarter 2026), +3% from Q2 2026.
How has Treace Medical Concepts' R&D spending changed?
Over the last 7 quarters it ranged from $4.4M (Q2 2026) to $5.6M (Q1 2025).
Q3 2026 results → · How Treace Medical Concepts makes money →